Skip to main content
. 2022 Aug 24;16(1):30–40. doi: 10.1093/ckj/sfac187

Figure 3:

Figure 3:

Proposed algorithm for the screening, diagnosis, assessment and treatment of CKD-aP among patients undergoing HD. *Treatment selection dependent on the availability of difelikefalin. Ca, calcium; NRS, numerical rating scale; P, phosphorus; PTH, parathyroid hormone; SSRI, selective serotonin reuptake inhibitor; UVB, ultraviolet B; VRS, verbal rating scale.